drugset

drugset / Trial / NCT00438776

Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling

NCT00438776 ↗

Phase 3 Completed 42 enrolled Lindner Center of HOPE Eli Lilly and Company · collab University of Cincinnati · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to evaluate the efficacy (effectiveness) and safety of olanzapine in treating pathological gambling.

Timeline

Start: 2007-02
Primary completion: 2009-03
Completion: 2009-03

Publications

Results McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE Jr. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry. 2008 Mar;69(3):433-40. doi: 10.4088/jcp.v69n0314.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Olanzapine	Small molecule	2.5 mg	—
Comparator	Olanzapine	Small molecule	15 mg	—

Indications